Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Westwater Resources Inc
Forum | Tag | Subject | View | Poster | |||||
---|---|---|---|---|---|---|---|---|---|
ASX - By Stock | WWR | Ann: Removal from Official List today | Thread | ASX News | 0 | 789 | 0 | 20/10/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Removal from Official List | Thread | ASX News | 0 | 562 | 0 | 20/10/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Suspension from Official Quotation-Close of Trading 13/10/17 | Thread | ASX News | 0 | 582 | 0 | 13/10/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Appendix 3B | Thread | ASX News | 0 | 552 | 0 | 09/10/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Form 8-K | Thread | ASX News | 0 | 534 | 0 | 29/09/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Prospectus Supplement | Thread | ASX News | 0 | 1.2K | 0 | 29/09/17 | |
|
|||||||||
ASX - By Stock | WWR | Ann: Common Stock Purchase Agreement | Thread | ASX News | 0 | 600 | 0 | 29/09/17 | |
|